Immutep Ownership

Stocks . USA . 
Stock . Immutep Ltd ADR
IMMP Stock  USD 1.90  0.01  0.52%   
Immutep Ltd ADR has a total of 145.56 Million outstanding shares. Roughly 97.94 (percent) of Immutep outstanding shares are held by general public with 0.01 % owned by insiders and only 2.05 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2012-12-31
Previous Quarter
1.2 B
Current Value
1.2 B
Avarage Shares Outstanding
445.8 M
Quarterly Volatility
395.3 M
 
Yuan Drop
 
Covid
As of 03/20/2025, Dividend Paid And Capex Coverage Ratio is likely to drop to -921.89. As of 03/20/2025, Common Stock Shares Outstanding is likely to grow to about 1.5 B, while Net Loss is likely to drop (37.7 M).
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immutep Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Immutep Stock Ownership Analysis

The book value of the company was currently reported as 0.12. The company recorded a loss per share of 0.21. Immutep Ltd ADR last dividend was issued on the 28th of December 2016. The entity had 3:10 split on the 28th of December 2016. Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products. Immutep Limited was incorporated in 1987 and is headquartered in Sydney, Australia. Immutep operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. To learn more about Immutep Ltd ADR call Marc Voigt at 61 2 8315 7003 or check out https://www.immutep.com.

Immutep Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Immutep is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Immutep Ltd ADR backward and forwards among themselves. Immutep's institutional investor refers to the entity that pools money to purchase Immutep's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Morgan Stanley - Brokerage Accounts2024-12-31
29.6 K
Rhumbline Advisers2024-12-31
28.7 K
Ubs Group Ag2024-12-31
23 K
Geode Capital Management, Llc2024-12-31
18.7 K
Old Mission Capital Llc2024-12-31
16.8 K
Millennium Management Llc2024-12-31
16.4 K
Simplex Trading, Llc2024-12-31
10.3 K
Tower Research Capital Llc2024-12-31
5.6 K
Royal Bank Of Canada2024-12-31
4.9 K
Blackrock Inc2024-12-31
740.4 K
Meridian Wealth Management, Llc2024-12-31
394.1 K
Note, although Immutep's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Immutep Outstanding Bonds

Immutep issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Immutep Ltd ADR uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Immutep bonds can be classified according to their maturity, which is the date when Immutep Ltd ADR has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp Bond
US235822AB96		View
US45258LAA52 Corp Bond
US45258LAA52		View
MPLX LP 4875 Corp Bond
US55336VAJ98		View
MPLX LP 52 Corp Bond
US55336VAL45		View
Morgan Stanley 3591 Corp Bond
US61744YAK47		View
Morgan Stanley 3971 Corp Bond
US61744YAL20		View
MGM Resorts International Corp Bond
US552953CD18		View
Valero Energy Partners Corp Bond
US91914JAA07		View

Additional Tools for Immutep Stock Analysis

When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY